Rosnilimab Shows Positive Phase 2b Results in RA Trial
AnaptysBio’s investigational drug, rosnilimab, has shown promising results in a Phase 2b trial for rheumatoid arthritisarthritis (RA). The drug...
Akeega® Improves Efficacy in HRR-Mutated mHSPC
Johnson & Johnson’s Phase 3 AMPLITUDE study demonstrates that the combination of niraparib and abiraterone acetate with prednisone significantly...
FlexiTouch® Plus Improves Lymphedema in Head & Neck Cancer Survivors
Tactile Medical presented two-month data from the largest randomized controlled trial on head and neck cancer-related lymphedema at the...
Efzofitimod Shows Promise in Systemic Sclerosis-ILD Phase 2 Study
aTyr Pharma released interim Phase 2 data for efzofitimod, a potential treatment for systemic sclerosis-related interstitial lung disease (SSc-ILD)....
Soquelitinib Atopic Dermatitis Trial Shows Promising Phase 1 Results
Corvus Pharmaceuticals released interim Phase 1 clinical trial data for soquelitinib, an oral ITK inhibitor, in patients with moderate...
Infoods® IBS Study Results Published in Gastroenterology
Biomerica’s inFoods IBS test, a personalized dietary therapy for Irritable Bowel Syndrome (IBS), demonstrated statistically significant improvement in patient...
Dyne Therapeutics Presents New FSHD Preclinical Data
Dyne Therapeutics announced preclinical data showing its drug candidate, DYNE-302, improved muscle function in a mouse model of facioscapulohumeral...
Rectify Pharma Improves Kidney Function, Reduces Vascular Calcification
Rectify Pharmaceuticals presented data on RTY-822, a positive functional modulator (PFM) targeting the ABCC6 membrane transporter, at the 2025...
Actuate Doubles Survival in Pancreatic Cancer Trial
Actuate Therapeutics’ Phase 2 trial of elraglusib combined with gemcitabine/nab-paclitaxel (GnP) achieved its primary endpoint, demonstrating a statistically significant...
Impact Biotech’s Padeliporfin Shows Promising Interim Results in Phase 3 Study
ImPact Biotech announced interim Phase 3 trial results for Padeliporfin VTP, a treatment for low-grade upper tract urothelial cancer...